Autophagy and oxidative stress in solid tumors: Mechanisms and therapeutic opportunities

María Carretero-Fernández1, Antonio José Cabrera-Serrano2, José Manuel Sánchez-Maldonado2

  • 1Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada 18016, Spain; Instituto de Investigación Biosanitaria IBs.Granada, Granada 18012, Spain; Medical Oncology Unit, University Hospital of Jaén, Jaén 23007, Spain.

Insights

Autophagy and oxidative stress are key cellular processes in solid tumors. Understanding their complex interplay can reveal new cancer treatment strategies and improve patient outcomes.

Area of Science:

  • Oncology
  • Cellular Biology
  • Biochemistry

Background:

  • Cancer is a major global health issue, with solid tumors being the most common type.
  • Autophagy and oxidative stress are critical cellular mechanisms influencing cancer development and response to treatment.
  • These processes have dual roles, acting as tumor suppressors or promoters depending on the context.

Purpose of the Study:

  • To review the intricate relationship between autophagy and oxidative stress in solid tumors.
  • To highlight the implications of this crosstalk for tumor progression and therapeutic strategies.
  • To explore potential novel therapeutic approaches targeting these pathways.

Main Methods:

  • Literature review of studies on autophagy, oxidative stress, and solid tumors.
  • Analysis of the interconnected roles of these mechanisms in tumorigenesis and treatment resistance.
  • Examination of pharmacological targeting strategies and their associated challenges.

Main Results:

  • Autophagy and oxidative stress (ROS imbalance) have context-dependent roles in cancer, influencing initiation, progression, and survival.
  • Their crosstalk impacts the tumor microenvironment, affecting immune evasion, drug resistance, and metabolic adaptation.
  • Targeting these pathways offers therapeutic opportunities but also presents challenges like potential systemic toxicity.

Conclusions:

  • The interplay between autophagy and oxidative stress is crucial in solid tumors, impacting various aspects of cancer biology.
  • Understanding these mechanisms is vital for developing innovative cancer therapies, including combination and precision medicine approaches.
  • Further research into modulating autophagy and oxidative stress could lead to improved patient outcomes in cancer treatment.

Related Concept Videos

Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
7.3K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K